>
Something BIG Is Coming... Keep Your Eye on BlackRock | Redacted w Clayton Morris
Hamas Submits 'Positive Response' To US-Backed Ceasefire As Pressure Mounts On Netanyahu
Victor Davis Hanson Dismantles "Experts" Who Keep Getting Trump Wrong
21 States Across US Now Reporting COVID 'Razor Throat' Variant
xAI Grok 3.5 Renamed Grok 4 and Has Specialized Coding Model
AI goes full HAL: Blackmail, espionage, and murder to avoid shutdown
BREAKING UPDATE Neuralink and Optimus
1900 Scientists Say 'Climate Change Not Caused By CO2' – The Real Environment Movement...
New molecule could create stamp-sized drives with 100x more storage
DARPA fast tracks flight tests for new military drones
ChatGPT May Be Eroding Critical Thinking Skills, According to a New MIT Study
How China Won the Thorium Nuclear Energy Race
Sunlight-Powered Catalyst Supercharges Green Hydrogen Production by 800%
Experts said the breakthrough - which spots changes in the genes, as disease develops - could be used to improve screening for cancer, allowing treatment much sooner, when it is more likely to succeed.
Crucially, 99.4 per cent cases identified as cancer were correctly spotted - meaning just 0.6 per cent of cases were misdiagnoses of healthy patients.
The test was able to detect one third of patients with stage one disease, and three quarters of those with stage two disease.
Ministers have pledged to speed diagnosis, so that by 2028 three quarters of cancer patients are diagnosed at these two stages. Currently just half of patients can expect to receive a diagnosis before they reach stage three or four.
The advances, by US scientists, look for abnormal patterns of methylation in the DNA, which can indicate different types of cancer.